KRYS · short Krystal Biotech INC
Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…
NASDAQ
Krystal Biotech, Inc.
KRYS
1 story
$9.5B Market cap · 2026-10-21
KRYS · short 